FDA APPROVAL
-
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Huntington's disease is an inherited condition that causes the progressive breakdown of nerve cells in the brain, resulting in a gradual decline in motor control, cognition and mental stability.
-
Lupin receives US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent
-
U.S. FDA approves ImmunityBio's bladder cancer therapy
-
First law protecting consumers' brainwaves signed by Colorado governor
-
Wegovy to be covered by US Medicare for heart disease patients
-
CutisPharma in pact with DRL
Advertisement
Advertisement